Understanding When to Treat Recurring Prostate Cancer: A Balanced Approach
After successful prostate cancer treatment, a rising PSA level can be confusing and concerning. This situation — known as a biochemical recurrence — does not always mean that the cancer has visibly returned. For many men, PSA can rise slowly over years before any structural disease appears on conventional imaging. Harvard Health
What Does Biochemical Recurrence Mean?
When PSA (prostate-specific antigen) rises after primary therapy but no tumor is seen on standard imaging scans, this is called a biochemical recurrence. It reflects prostate cancer cells somewhere in the body — but they may be too small to detect or slow-growing. Harvard Health
With newer and more sensitive scans like PSMA PET imaging, very small areas of disease can now be detected earlier. While this helps us see more, it also raises questions: Does earlier detection mean immediate treatment is necessary? Harvard Health
New Thinking in Recurrence Management
Experts now recognize that even when PSMA imaging shows small spots of cancer recurrence, immediate aggressive treatment may not always be the best option for every man. Some important points doctors consider include: Harvard Health
-
PSA doubling time: If PSA levels rise slowly, the cancer may not progress rapidly, and close monitoring can be an option. Harvard Health
-
Age and overall health: Older men or those with other health conditions might choose to delay therapy in favor of quality of life. Harvard Health
-
Extent of disease on scans: Fewer and smaller PSMA-detected spots may allow for careful observation rather than immediate hormonal therapy or other treatments. Harvard Health
-
Personal goals: Treatment choices should align with what matters most to the patient — from reducing side effects to maintaining everyday functioning. Harvard Health
Why Not Treat Right Away?
Traditional treatments like hormone therapy (which blocks testosterone) can delay cancer progression and lower PSA levels, but they also carry side effects — including fatigue, bone thinning, and metabolic changes. Currently, there’s limited evidence that treating a recurrence purely based on PSMA imaging improves overall survival. Harvard Health
Making the Right Decision
The best approach is a personalized plan made together with your healthcare provider. A thoughtful discussion should include:
-
Recent PSA trends
-
Scan findings
-
Patient’s age, health conditions, and treatment goals
-
Risks and benefits of starting treatment now versus monitoring closely Harvard Health
Monitoring may involve regular PSA tests and periodic imaging to track changes over time.
🧠Conclusion
A rising PSA after prostate cancer treatment doesn’t always mean an urgent need for therapy — especially with slow rises and minimal disease on imaging. In many cases, close monitoring with regular follow-ups can be a safe and thoughtful strategy that preserves quality of life without compromising outcomes. However, every patient’s situation is different, and choices should be guided by both clinical evidence and personal preferences. Harvard Health
— Dr. Chithra S, Shree Polyclinic & Lab

Comments
Post a Comment